TEVERELIX-TFA COMPOSITION
The present invention relates to a teverelix-TFA composition having a molar ratio of teverelix to trifluoroacetate composition of at least 1:2.2. Such a molar ratio will prevent undesirable gel-formation and provide a homogenous suspension, whereby a unique bioavailablity of teverelix is obtained.
Saved in:
| Main Authors | , |
|---|---|
| Format | Patent |
| Language | English French German |
| Published |
08.01.2020
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention relates to a teverelix-TFA composition having a molar ratio of teverelix to trifluoroacetate composition of at least 1:2.2. Such a molar ratio will prevent undesirable gel-formation and provide a homogenous suspension, whereby a unique bioavailablity of teverelix is obtained. |
|---|---|
| AbstractList | The present invention relates to a teverelix-TFA composition having a molar ratio of teverelix to trifluoroacetate composition of at least 1:2.2. Such a molar ratio will prevent undesirable gel-formation and provide a homogenous suspension, whereby a unique bioavailablity of teverelix is obtained. |
| Author | Poland, Guy BOUTIGNON, François |
| Author_xml | – fullname: Poland, Guy – fullname: BOUTIGNON, François |
| BookMark | eNrjYmDJy89L5WSQDHENcw1y9fGM0A1xc1Rw9vcN8A_2DPH09-NhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGuAcamlgamRqaOhsZEKAEAuWchlA |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | COMPOSITION TEVERELIX-TFA TEVERELIX-TFA-ZUSAMMENSETZUNG |
| ExternalDocumentID | EP3590525A1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_EP3590525A13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Sep 06 06:22:37 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English French German |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_EP3590525A13 |
| Notes | Application Number: EP20180181945 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200108&DB=EPODOC&CC=EP&NR=3590525A1 |
| ParticipantIDs | epo_espacenet_EP3590525A1 |
| PublicationCentury | 2000 |
| PublicationDate | 20200108 |
| PublicationDateYYYYMMDD | 2020-01-08 |
| PublicationDate_xml | – month: 01 year: 2020 text: 20200108 day: 08 |
| PublicationDecade | 2020 |
| PublicationYear | 2020 |
| RelatedCompanies | Antev Limited |
| RelatedCompanies_xml | – name: Antev Limited |
| Score | 3.2399352 |
| Snippet | The present invention relates to a teverelix-TFA composition having a molar ratio of teverelix to trifluoroacetate composition of at least 1:2.2. Such a molar... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | TEVERELIX-TFA COMPOSITION |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200108&DB=EPODOC&locale=&CC=EP&NR=3590525A1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSQH2o1MSE810gZVfiq6JJTArWhqbGuuaGqQmJ1qmplimWIL2Dvv6mXmEmnhFmEYwMWTC9sKAzwktBx-OCMxRycD8XgIurwsQg1gu4LWVxfpJmUChfHu3EFsXNWjvGLRAyMBCzcXJ1jXA38XfWc3ZGchS8wuyNTa1BN3Y5gjsKLECW9HmoNVfrmFOoE0pBcg1ipsgA1sA0LC8EiEGptQ8YQZOZ9jFa8IMHL7Q-W4gE5r1ikUYJENcw1yDXH08I3RD3BwVnP19A_yDPUEDTKIMCm6uIc4eukA74uH-iXcNgLvGWIyBBdjNT5VgUDBKSTJLMje0TLQwA_ZZzRItgd4xtLRIM0k0M0y1MDSWZJDEaYwUHjlpBi5QwICHDSxkGFhKikpTZYEVaUmSHDgIAA4fc4c |
| link.rule.ids | 230,309,783,888,25578,76884 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT4MwEL8s0zjfdGrETx4Mb8QhUOkDMVspAeUrExfeCAyW7GUuDuO_75Ww6Yu-Xdrk2rvkev1de3cAdxXi6KooiIrOr1INiqZIdVNXzVE9L2hd0YqK3OEwIt6b8ZyZWQ-W21yYtk7oV1scES1qjvbetOf1-ieI5bR_Kzf35RKH3p_c1HaUDh2LD0IjS3EmNk9iJ2YKY0gp0dTWTSo6to0RKO3hDdsSZfb5bCKSUta_PYp7BPsJMls1x9CrV0MYsG3jtSEchN17N5Kd6W1OQEr5jE954Gdq6o5lFodJ_OqLANMpyC5PmafiGvlOnpwnu93oZ9BHmF-fg_xQlaR81GhhEcSspKAojkathVEQrbY0XQLpTzYX_8zdwsBLwyAP_OjlEg6FktoQgnUF_ebjs75Gp9qUN606vgGgSnZ3 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=TEVERELIX-TFA+COMPOSITION&rft.inventor=Poland%2C+Guy&rft.inventor=BOUTIGNON%2C+Fran%C3%A7ois&rft.date=2020-01-08&rft.externalDBID=A1&rft.externalDocID=EP3590525A1 |